Nick Fels Portfolio
Invests via Talaria Asset Management Pty Ltd | Managed by Chad Padowitz, Hugh Selby-Smith
Invests via Talaria Asset Management Pty Ltd
Managed by Chad Padowitz, Hugh Selby-Smith
Automatically Tracked
Nick Fels Profile
Veteran early-stage technology investor and operator focused on SaaS, marketplaces and fintech, active in seed and pre-Series A rounds. Nick Fels brings entrepreneurial operating experience, board and advisory roles, and a hands-on approach to product and go-to-market scaling. Frequently leads syndicates and partners with founders on KPI-driven growth, unit economics, and fundraising strategy. Relevant to LPs and acquirers evaluating founder-market fit and early-capital structuring.
Veteran early-stage technology investor and operator focused on SaaS, marketplaces and fintech, active in seed and pre-Series A rounds. Nick Fels brings entrepreneurial operating experience, board and advisory roles, and a hands-on approach to product and go-to-market scaling. Frequently leads syndicates and partners with founders on KPI-driven growth, unit economics, and fundraising strategy. Relevant to LPs and acquirers evaluating founder-market fit and early-capital structuring.
Investment Philosophy & Strategy
Focuses on early-stage SaaS, marketplaces and fintech with a hands-on, founder-focused investing style. Prioritizes seed and pre‑Series A opportunities where product-market fit can be accelerated through KPI-driven go‑to‑market and unit‑economics work. Prefers to lead or co‑lead syndicates, using operating experience to shape roadmaps, hiring, and fundraising tactics. Capital allocation favors companies with clear revenue and retention signals, defensible distribution channels, and paths to efficient customer acquisition. Time horizon is growth-oriented but pragmatic about capital efficiency and exit optionality; risk discipline centers on founder-market fit, measurable traction, and scalable unit metrics. Adds value through board/advisory engagement, playing an active role in strategy, hiring, and buyer/LP positioning.
Focuses on early-stage SaaS, marketplaces and fintech with a hands-on, founder-focused investing style. Prioritizes seed and pre‑Series A opportunities where product-market fit can be accelerated through KPI-driven go‑to‑market and unit‑economics work. Prefers to lead or co‑lead syndicates, using operating experience to shape roadmaps, hiring, and fundraising tactics. Capital allocation favors companies with clear revenue and retention signals, defensible distribution channels, and paths to efficient customer acquisition. Time horizon is growth-oriented but pragmatic about capital efficiency and exit optionality; risk discipline centers on founder-market fit, measurable traction, and scalable unit metrics. Adds value through board/advisory engagement, playing an active role in strategy, hiring, and buyer/LP positioning.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
50.29%
Gain +0.73%
Monthly
2.05%
Yearly
27.66%
Drawdown
13.79%
$524.47M
Equity
Holdings
$524.47M
Investment
$464.89M
$185.2M
Profit +$3.53M
Realized
$125.62M
Unrealized
$59.58M
Dividends
$24.78M
Goals
Avg. 100% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
0.73%
Profit
$3.53M
Win %
79%
This Week
Compared To Last Week
Gain
1.34%
Profit
$6.93M
Win %
79%
This Month
Compared to last month
Gain
0.68%
Profit
$3.53M
Win %
79%
This Year
Compared to last year
Gain
12.07%
Profit
$56.47M
Win %
69%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 60 | Longs Won 44/60 73% | Profit Factor 13.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $6.63M |
| Average Win $4.55M | Best Trade (Dec 30) $44.96M | Sharpe Ratio -10.75 |
| Average Loss -$931,292.69 | Worst Trade (Sep 01) -$5.34M | Z-Score 3.36 (99.92%) |
| Commissions $0 | Avg. Trade Length 8m 2w 3d | Expectancy $3.09M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.04% |
| Consecutive Losing Trades | 563 | 507 | 450 | 394 | 338 | 282 | 225 | 169 | 113 | 56 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
 ADBE Adobe Inc. | 38,000 | $9.24M | $10.03M | - | $795,719.58 | 8.61% | -2.392% |
 AOS A. O. Smith Corporation | 1.2M | $77.83M | $74.65M | - | -$3.18M | -4.09% | -0.528% |
 CB Chubb Limited | 103,800 | $29.3M | $35.67M | - | $6.37M | 21.75% | -0.25% |
 DOX Amdocs Limited | 130,500 | $10.9M | $7.6M | - | -$3.3M | -30.27% | -0.75% |
 EG Everest Group, Ltd. | 281,800 | $99.9M | $104.3M | - | $4.4M | 4.4% | +1.109% |
 EOG EOG Resources, Inc. | 267,700 | $28.11M | $38.18M | - | $10.07M | 35.81% | +0.849% |
 HPQ HP Inc. | 2.04M | $44.22M | $61.52M | - | $17.3M | 39.12% | -3.802% |
 MDT Medtronic plc | 729,900 | $58.52M | $66.62M | - | $8.1M | 13.84% | +0.762% |
 NEM Newmont Corporation | 26,800 | $2.9M | $3.16M | - | $254,868 | 8.79% | +3.126% |
 PFE Pfizer Inc. | 1.66M | $40.44M | $44.37M | - | $3.93M | 9.72% | -0.037% |
 RHI Robert Half Inc. | 928,900 | $31.11M | $40.15M | - | $9.03M | 29.03% | -1.279% |
 WEC WEC Energy Group Inc. | 291,300 | $32.42M | $32.19M | - | -$228,203 | -0.7% | +0.218% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Nick Fels?
The largest contributions to the portfolio's profits come from the following stocks: Newmont Corporation - $45.82M, Johnson & Johnson - $21.53M, Johnson Controls International plc - $12.65M, Ambev S.A - $11.98M, and Cenovus Energy Inc - $10.19M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: Amdocs Limited - $1.71M. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does Nick Fels's portfolio generate?
The portfolio generates substantial dividend income, with a total of $24.78M earned over time. The largest contributors to dividend income include Pfizer Inc - $3.39M, Ambev S.A - $2.83M, Medtronic plc - $2.11M, Everest Group, Ltd - $2.05M, and Fomento Economico Mexicano S.A.B. de C.V. ADR - $1.88M. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Nick Fels's monthly returns?
Nick Fels's monthly returns show a mixed pattern. Some months are relatively calm, while others are noticeably stronger or weaker, which suggests that performance is not fully consistent over time. This points to a strategy that may offer attractive upside but can also experience uneven short-term results.
Can Nick Fels's strategy be considered aggressive or moderate?
Nick Fels's strategy can be described as moderate. It balances growth potential with risk management, showing a willingness to accept some volatility while still maintaining a relatively structured and diversified approach.
Should beginners follow Nick Fels's strategy?
Nick Fels's strategy may be suitable for beginners, but with some caution. While the overall approach is not overly complex, it still involves a certain level of risk and variability. Beginners should be prepared for occasional fluctuations and ensure they understand the strategy before trying to follow it.
